510(k) K214068

Quantia IgE by Biokit, S.A. — Product Code DGC

K214068 is an FDA 510(k) premarket notification submitted by Biokit, S.A. for the device "Quantia IgE". The FDA issued a decision of Substantially Equivalent on February 21, 2023. The device falls under product code DGC (Ige, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5510. Biokit, S.A. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 21, 2023
Date Received
December 27, 2021
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Ige, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5510
Review Panel
IM
Submission Type